TVTimo-Daniel Voss

Timo-Daniel Voss

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Timo-Daniel Voss has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    C-terminal lysine residues localise NLRP10 at lipid droplets and govern NLRP10 oligomer formation

    by Timo-Daniel Voss, Christoph Winterberg, Adrian Beck, Clarissa Gottschild, Leonie Mueller, Selina M Enayat, Matthias Geyer, Thomas A Kufer

    NLRP10 is an atypical member of the NLR family because it lacks a leucine-rich repeat domain at its C-terminus. Here, we show that in human epithelial cells and keratinocytes NLRP10 oligomerises in response to m -3M3FBS and SC-10 treatment. NLRP10 co-localises with ASC upon overexpression, but ASC nucleation and recruitment are different to NLRP3. While neither ATP hydrolysis nor the pyrin domain is required, the C-terminal tail region is both necessary and sufficient for oligomerisation. The generation of chimeric proteins shows that the tail region of human and mouse NLRP10 has a conserved function in oligomerisation but determines different protein stabilities. Changes in the subcellular localisation of NLRP10 and oligomerisation are dependent on the presence of evolutionarily conserved lysine residues in the tail region, which localise the majority of NLRP10 to lipid droplets. Our study identifies the C-terminal basic tail of NLRP10 as a key regulatory element for oligomerisation and localisation at lipid interfaces. These findings underline differences in NLRP10 activation with respect to other inflammasome-forming NLRPs and suggest a role of lipids in NLRP10 activation.

  • Open Access

    C-terminal lysine residues localise NLRP10 at lipid compartments and govern NLRP10 oligomer formation

    by Timo-Daniel Voss, Christoph Winterberg, Adrian Beck, Clarissa Gottschild, Leonie Mueller, Selina M. Enayat, Matthias Geyer, Thomas A. Kufer

    NLRP10 is an atypical member of the NOD-like receptor (NLR) family because it lacks a leucine-rich repeat domain at its C-terminus. Recently, NLRP10 has been shown to form an inflammasome, however, the mechanism and the trigger of activation remain elusive. Here, we show that in human epithelial cells and keratinocytes NLRP10 oligomerises in response to the stressor m -3M3FBS. NLRP10 co-localises with ASC upon overexpression, but ASC nucleation and recruitment were different to other NLRPs. While neither ATP hydrolysis nor the pyrin domain were required, the C-terminal tail region (aa 584-655) was both necessary and sufficient for oligomerisation. Generation of chimeric proteins showed that the function of the tail is conserved between human and mouse NLRP10 in respect to aggregation but convers different protein stability. Changes in the subcellular localisation of NLRP10 and oligomerization were dependent on the presence of evolutionarily conserved lysine residues in the tail region, which localise the majority of NLRP10 at lipid droplets. Our study identifies the C-terminal basic tail of NLRP10 as a key regulatory element for oligomerisation and localisation at lipid interfaces. These findings underline differences of NLRP10 activation in respect to other inflammasome forming NLRPs and suggest a role of lipids in NLRP10 activation.

  • Pattern Recognition by NOD-Like Receptors

    by Timo-Daniel Voss, Lucy Hezinger, Thomas A. Kufer

    Nucleotide-binding oligomerization domain-like receptors (NLRs) are a family of cytosolic pattern recognition receptors (PRRs) and able to respond to conserved microbe-associated molecular patterns (MAMPs) and endogenous damage-associated molecular patterns (DAMPs). NLRs modulate the inflammatory response via multiple pathways including nuclear factor kappa-light chain-enhancer of activated B cells (NF-κB)-activation, mitogen-activated protein kinase (MAPK)-pathways and both canonical and non-canonical inflammasome formation. The latter results in auto-processing of caspase-1 and subsequent maturation of the cytokines interleukin 1 beta (IL-1β) and IL-18 as well as induction of pyroptosis by cleavage of gasdermin D (GSDMD) that induces pores in the cell membrane. NLRs act in synergy with other PRRs but some NLRs directly modulate adaptive immunity via transcriptional regulation of major histocompatibility complex (MHC) class I and class II. NLRs have an essential role as intracellular PRRs and thereby orchestrate inflammatory responses. NLR mutations and subsequent dysfunction can result in cancer or autoinflammatory diseases, such as Crohn’s disease and ulcerative colitis, and many more, indicating their important role in classical immune recognition, maintenance of tissue homeostasis and reproductive functions. Here, we discuss our current understanding of mammalian NLRs that act as PRRs.


  • Open Access

    Opsonization-independent antigen-specific recognition by myeloid phagocytes expressing monoclonal antibodies

    by Michael Neumaier, Sophie Giesler, Volker Ast, Mathis Roemer, Timo-Daniel Voß, Eileen Reinz, Victor Costina, Martin Schmelz, Elina Nürnberg, Stefanie Nittka, et al.

    This report demonstrates a novel class of innate immune cells designated “variable immunoreceptor–expressing myeloids” (VIREMs). Using single-cell transcriptomics and genome-wide epigenetic profiling, we establish that VIREMs are myeloid cells unrelated to lymphocytes. We visualize the phenotype of B-VIREMs that are capable of genetically recombining and expressing antibody genes, the exclusive hallmark function of B lymphocytes. These cells, designated B-VIREMs, display monoclonal antibody cell surface signatures and regularly circulate in the blood of healthy individuals. Single-cell data reveal clonal expansion of circulating B-VIREMs as a dynamic response to disease stimuli. Live-cell imaging models suggest that B-VIREMs load their own Fc receptors with endogenous antibodies during vesicle transport to the cell surface. A first cloned B-VIREM–derived antibody (Vab1) specifically binds stomatin, a ubiquitous scaffold protein that is strictly expressed intracellularly, allowing Vab1-bearing macrophages to phagocytose cell debris without requiring prior opsonization. Our results suggest important antigen-specific tissue maintenance functionalities in these innate immune cells.


  • Open Access

    Murine RAW Macrophages Are a Suitable Model to Study the CD3 Signaling in Myeloid Cells

    by Ranferi Ocaña-Guzmán, Lucero A. Ramón-Luing, Michelle Rodríguez-Alvarado, Timo-Daniel Voss, Tina Fuchs, Leslie Chavez-Galan

    In recent years, a growing body of evidence has shown the presence of a subpopulation of macrophages that express CD3, especially in the context of mycobacterial infections. Despite these findings, the function of these cells has been poorly understood. Furthermore, the low frequency of CD3+ macrophages in humans limits the study of this subpopulation. This work aimed to evaluate the expression of CD3 in a murine macrophage cell line and its potential for the study of CD3 signaling. The murine macrophage cell line RAW was used to evaluate CD3 expression at the transcriptional and protein levels and the effect of in vitro infection with the Mycobacterium bovis Bacillus Calmette-Guérin (BCG) on these. Our data showed that RAW macrophages express CD3, both the ε and ζ chains, and it is further increased at the transcriptional level after BCG infection. Furthermore, our data suggest that CD3 can be found on the cell surface and intracellularly. However, this molecule is internalized constantly, mainly after activation with anti-CD3 stimulus, but interestingly, it is stably maintained at the transcriptional level. Finally, signaling proteins such as NFAT1, c-Jun, and IKK-α are highly expressed in RAW macrophages. They may play a role in the CD3-controlled signaling pathway to deliver inflammatory cytokines such as TNF and IL-6. Our study provides evidence to support that RAW cells are a suitable model to study the function and signaling of the CD3 complex in myeloid cells.